Brief: Kuros Biosciences AG Says Appointed Daniel Geiger As Chief Financial Officer (CFO) Ad Interim, Effective February 17, 2023
Feb 16 (Reuters) - Kuros Biosciences AG KURN.S :
* DANIEL GEIGER AS CHIEF FINANCIAL OFFICER (CFO) AD INTERIM,
EFFECTIVE FEBRUARY 17, 2023
* DANIEL GEIGER SUCCEEDS MICHAEL GRAU, WHO WILL HANDOVER HIS
CFO
POSITION
Source text for Eikon: ID:nEQ68y1Hda
Further company coverage: KURN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kuros Biosciences AG
See all newsSwitzerland's Kuros Biosciences swing to H1 profit as revenue jumps
Brief: Kuros Biosciences H1 Gross Profit USD 79.965 Million
Europe Research Roundup: Avanza Bank, Forvia, Novonesis
Switzerland's Kuros Biosciences 2025 total medical device revenue rises, helped by MagnetOs growth
Brief: Kuros Biosciences FY Net Income USD 2.462 Million